Gilead Sciences
Article Abstract:
A comparative analysis of the company sales and earnings and the financial details of Gilead Sciences from 1994 - 2003 are illustrated. Projections of the equity price of this company for 2004 - 2005 is made using Value Line estimates.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2004
Sales, profits & dividends, Company sales and earnings, Company earnings/profit
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Stock highlight: Gilead Sciences (GILD-45.65)
Article Abstract:
Reports on the growth and stock performance of Gilead Sciences, a biopharmaceutical company, are presented. The prospects of buying the company's stocks are evaluated.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 2 - Selection & Opinion)
Subject: Business, general
ISSN:
Year: 2003
Growth, Company growth
Publication Name: The Value Line Investment Survey (Part 2 - Selection & Opinion)
Subject: Business, general
ISSN:
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
Subjects list: United States, Biological products industry, Securities, Gilead Sciences Inc., GILD, Company securities
Similar abstracts:
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.